Fairfield, Bush & Co’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-250
Closed -$21.7K 285
2023
Q4
$21.7K Buy
+250
New +$20.7K 0.01% 248
2023
Q3
Sell
-250
Closed -$21.2K 300
2023
Q2
$21.2K Buy
+250
New +$21.3K 0.01% 269
2022
Q3
Sell
-250
Closed -$20K 280
2022
Q2
$20K Buy
+250
New +$20.9K 0.01% 256
2018
Q2
Sell
-400
Closed -$22K 173
2018
Q1
$22K Buy
+400
New +$23K 0.01% 178
2017
Q1
Sell
-4,400
Closed -$209K 148
2016
Q4
$209K Hold
4,400
0.07% 144
2016
Q3
$222K Buy
+4,400
New +$226K 0.07% 138

Other funds holding IXJ

Fairfield, Bush & Co's IXJ Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of iShares Global Healthcare ETF (IXJ) in Q1 2024, closing a stake of 250 shares — an estimated $21.7K sold.

Fairfield, Bush & Co first reported a position in IXJ in Q3 2016 and held it in 6 quarters. The position peaked at $222K in Q3 2016. 269 funds tracked by Wall St. Rank hold IXJ as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining iShares Global Healthcare ETF position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 250 iShares Global Healthcare ETF shares in Q1 2024, an estimated $21.7K.
  • Fairfield, Bush & Co first reported a position in iShares Global Healthcare ETF in Q3 2016 and held it in 6 quarters.
  • Fairfield, Bush & Co's iShares Global Healthcare ETF position peaked at $222K in Q3 2016.
  • 269 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.